Edgar Engleman, Director at Bolt Biotherapeutics, Inc. (BOLT), sold 49,173 shares at $0.92 ($46K) on 2023-11-20, disclosed to the SEC on 2023-11-20.
Open-market sale of $46k BOLT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.96 | 1,040 | $998 | 2.2% |
| 2 | $0.96 | 7,531 | $7K | 15.8% |
| 3 | $0.93 | 1,134 | $1K | 2.3% |
| 4 | $0.93 | 8,211 | $8K | 16.7% |
| 5 | $0.92 | 3,792 | $3K | 7.6% |
| 6 | $0.92 | 27,465 |
| $25K |
| 55.3% |
| Total | $0.93 avg | 49,173 | $46K | 100% |
| Filing → |
| BOLT | BUY | 2021-02-09 | $4.0M | — | Filing → |
| BOLT | SELL | 2021-02-09 | $3K | — | Filing → |
| SLNO | BUY | 2017-12-19 | $4.0M | — | Filing → |